Skip to main content
. Author manuscript; available in PMC: 2021 Sep 16.
Published in final edited form as: Radiat Res. 2020 Sep 16;194(3):259–276. doi: 10.1667/RR15571.1

FIG. 3.

FIG. 3.

Panels A–G: Dose response (and 95% CI) over 0–3 Gy unadjusted absorbed colon dose for mortality from (panel A) solid cancer, (panel B) lung cancer, (panel C) stomach cancer, (panel D) breast cancer, (panel E) all solid cancer apart from lung, stomach, breast, (panel F) leukemia, (panel G) circulatory disease. Log-linear models using a factor dose variable are fitted by maximum likelihood with stratification by city, sex, ground distance (<3 km, >3 km from hypocenters), age at exposure, attained age, calendar period of follow-up. The CI are estimated from the profile likelihood. The mean dose used is the posterior mean from the stage 1 Bayesian MCMC models.